The biochemical basis of gangliosidoses.
D001921:Brain / Q000201:enzymology; D002648:Child; D005347:Fibroblasts / Q000201:enzymology; D005677:G(M1) Ganglioside / Q000378:metabolism*; D049289:G(M2) Activator Protein; D005678:G(M2) Ganglioside / Q000378:metabolism*; D005732:Gangliosides / Q000378:metabolism*; D005733:Gangliosidoses / Q000201:enzymology* / Q000235:genetics; D006023:Glycoproteins; D006596:Hexosaminidases / Q000172:deficiency; D006801:Humans; D008247:Lysosomes / Q000201:enzymology; D009154:Mutation; D011488:Protein Deficiency; D011506:Proteins; D012497:Sandhoff Disease / Q000201:enzymology* / Q000235:genetics; D049231:Saposins; D049128:Sphingolipid Activator Proteins; D013661:Tay-Sachs Disease / Q000201:enzymology* / Q000235:genetics; D001616:beta-Galactosidase / Q000172:deficiency; D001619:beta-N-Acetylhexosaminidases
D049289:G(M2) Activator Protein; D005732:Gangliosides; D006023:Glycoproteins; C483345:PSAP protein, human; D011506:Proteins; D049231:Saposins; D049128:Sphingolipid Activator Proteins; D005678:G(M2) Ganglioside; D005677:G(M1) Ganglioside; D006596:Hexosaminidases; C021502:acid beta-galactosidase; D001616:beta-Galactosidase; D001619:beta-N-Acetylhexosaminidases